ESRRG has been identified as a candidate tumor suppressor gene in gastric cancer that can inhibit Wnt signaling via the suppression of transcription factor 4 (TCF4)/lymphoid enhancer-binding factor 1 (LEF1), binding to the Cyclin D1 (CCND1) promoter [25]. This evidence concerns the gene CCND1 and neoplasm.